Tomaz Crochemore/LinkedIn
Jun 29, 2026, 15:07
Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
Tomaz Crochemore, Intensivist at Hospital Moriah, Fellow at the University of Zurich, shared a post on LinkedIn:
“From Bleeding to Thrombosis: The Era of Precision Hemostatic Medicine Has Arrived
Join us for the 14th Einstein International Symposium on Thrombosis and Hemostasis and the PBM: Focus on Hemostasis (SBTH) course.
A scientific journey dedicated to the practical application of coagulation physiology at the bedside, featuring:
- Coagulopathy phenotypes
- Viscoelastic and specialized coagulation testing
- Goal-directed hemostatic management
- Patient Blood Management (PBM) and Patient Clot Management (PCM)
- Personalized hemostatic and antithrombotic therapies
- Real-world clinical case discussions
The right therapy. For the right patient. At the right time.
Precision Hemostatic Medicine – Personalizing Hemostasis.”
Find more posts featuring Tomaz Crochemore on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering